Which is obviously an exhortation that can just as usefully be applied self - critically... OK yeah, I worry, so I obviously rationalise & anaesthetise these anxieties accordingly — but in reality, my fully - invested portfolio is a resounding confirmation of my past, present &
continuing bullish stance on the markets.
Not exact matches
Analysts at Cantor Fitzgerald
continue to hold a
bullish stance on Spark Therapeutics Inc (NASDAQ: ONCE) after the U.S. Food and Drug Administration gave the company a critical recommendation for its therapy called Luxturna.
Reflecting that situation, the White House has maintained a
bullish stance on carbon capture and storage (or sequestration), which it
continues to call a «clean coal» technology.